U.S. markets close in 2 hours 12 minutes

Accolade, Inc. (ACCD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
12.50+0.09 (+0.73%)
As of 01:48PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close12.41
Bid12.47 x 800
Ask12.54 x 800
Day's Range12.29 - 12.87
52 Week Range4.61 - 22.92
Avg. Volume703,444
Market Cap909.834M
Beta (5Y Monthly)1.36
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for ACCD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Accolade, Inc.
    Daily – Vickers Top Buyers & Sellers for 06/16/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    8 months agoArgus Research
View more
  • PR Newswire

    Blue Shield of California Launches Virtual Blue Benefit Plan Incorporating Primary, Mental Health, and Specialty Care

    Blue Shield of California today unveiled its Virtual Blue health benefits plan offering members easy-to-access, comprehensive care through a team of "virtual-first" primary, behavioral, and specialist healthcare professionals.

  • GlobeNewswire

    Accolade Announces Results for Fiscal Third Quarter 2023

    Fiscal third quarter 2023 revenue of $90.9 million, a 9% increase compared to fiscal third quarter 2022 revenue of $83.5 million SEATTLE, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal third quarter ended November 30, 2022. “Accolade enters the new year having just concluded one of the strongest selling performances in our company’s history. Notably, the strength in our business is driven by the increasing diversity in our platfor

  • GlobeNewswire

    Accolade Announces Participation in 25th Annual Needham Growth Conference

    SEATTLE, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will participate in the 25th Annual Needham Growth Conference on Wednesday, January 11, 2023 and will host a fireside chat at 1:30 pm ET. A webcast and replay of the fireside chat will be available at About Accolade, Inc. Accolade (Nasdaq: ACCD) provides millions of people and their families with an exceptional healthcare experience that is personal, data driven and value based to he